Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856420) titled 'A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Intra-Cellular Therapies, Inc.
Condition:
Generalized Anxiety Disorder
Intervention:
Drug: JNJ-99245354
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: September 30, 2026 ...